Postmenopausal osteoporosis
Information
- Disease name
- Postmenopausal osteoporosis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05010590 | Active, not recruiting | Phase 4 | Anabolic Therapy in Postmenopausal Osteoporosis | March 24, 2022 | May 1, 2024 |
| NCT02822378 | Active, not recruiting | N/A | Dried Plums and Bone Health in Postmenopausal Women | June 1, 2016 | December 31, 2024 |
| NCT04338529 | Active, not recruiting | Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation | April 1, 2020 | November 1, 2024 | |
| NCT00092014 | Completed | Phase 3 | A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211) | September 1, 2002 | April 1, 2004 |
| NCT00092027 | Completed | Phase 3 | A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219) | March 19, 2003 | March 15, 2004 |
| NCT00092053 | Completed | Phase 3 | Study of Investigational Drug in Osteoporosis (MK-0217-908) | December 2004 | July 2005 |
| NCT00165698 | Completed | Phase 3 | Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women | May 2005 | July 2007 |
| NCT00238745 | Completed | Phase 2 | Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis. | August 2003 | March 2007 |
| NCT00239629 | Completed | Phase 4 | Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial | September 2005 | January 2007 |
| NCT00247273 | Completed | Phase 3 | A Study of Monthly Risedronate for Osteoporosis | October 2005 | April 2008 |
| NCT00293813 | Completed | Phase 2 | A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density | May 2006 | August 2008 |
| NCT00377819 | Completed | Phase 3 | Study of Transitioning From Alendronate to Denosumab | September 2006 | July 2008 |
| NCT00381251 | Completed | Phase 1 | Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation. | September 2006 | January 2007 |
| NCT00395395 | Completed | Phase 1 | Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women | October 2006 | |
| NCT00411125 | Completed | Phase 1 | Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal Women | August 2006 | November 2006 |
| NCT00541658 | Completed | Phase 3 | A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis | October 2007 | April 2010 |
| NCT00545051 | Completed | Phase 4 | A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis. | May 2006 | May 2009 |
| NCT00545363 | Completed | Phase 4 | A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP) | April 2006 | January 2008 |
| NCT00545909 | Completed | Phase 4 | BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis | March 2006 | August 2008 |
| NCT00567606 | Completed | N/A | Prevention of Osteoporosis in Breast Cancer Survivors | April 1, 2002 | December 1, 2007 |
| NCT00577421 | Completed | Phase 3 | Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO | June 2003 | January 2006 |
| NCT00578981 | Completed | N/A | Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women | August 2007 | July 2008 |
| NCT00676312 | Completed | Phase 1 | Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects | May 2008 | |
| NCT00745121 | Completed | N/A | Study Evaluating ASTRA TECH Implant System, OsseoSpeed™ Implants in the Upper Jaw in Women With Osteoporosis | July 16, 2008 | November 15, 2017 |
| NCT00778154 | Completed | Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate | January 2004 | December 2006 | |
| NCT00887965 | Completed | Phase 2 | A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab | June 2009 | August 2010 |
| NCT00890981 | Completed | Phase 3 | A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab | July 2009 | August 2010 |
| NCT00896532 | Completed | Phase 2 | Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density | June 3, 2009 | February 18, 2016 |
| NCT00909961 | Completed | Phase 3 | A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 Years | November 2009 | December 16, 2011 |
| NCT00918749 | Completed | Phase 2 | Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women | May 2009 | October 2009 |
| NCT00936897 | Completed | Phase 3 | A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates | July 2009 | January 2012 |
| NCT00996801 | Completed | Phase 2 | MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012) | November 2009 | June 2011 |
| NCT01128257 | Completed | A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis | April 2010 | December 2011 | |
| NCT01221727 | Completed | Phase 1 | The Effects of Denosumab on the Pharmacokinetics (PK) of Midazolam | November 2010 | July 2011 |
| NCT01321723 | Completed | Phase 2 | Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women | February 2011 | October 2011 |
| NCT01343004 | Completed | Phase 3 | Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women | April 2011 | October 2014 |
| NCT01348243 | Completed | Phase 3 | Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis | October 2011 | March 2013 |
| NCT01406613 | Completed | Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis | March 2010 | November 2015 | |
| NCT01501344 | Completed | N/A | Open-label Study to Evaluate the Effect of MBP-80 on Bone Remodelling | January 2011 | August 2011 |
| NCT01544894 | Completed | Phase 4 | Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis | September 2009 | October 2011 |
| NCT01572545 | Completed | N/A | Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass | April 2012 | January 2013 |
| NCT01575834 | Completed | Phase 3 | Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis | March 15, 2012 | December 28, 2016 |
| NCT01657162 | Completed | Phase 3 | Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis | November 20, 2012 | October 3, 2016 |
| NCT01668589 | Completed | Observational Study of Denosumab (Prolia®) in Postmenopausal Women With Osteoporosis | November 28, 2011 | August 31, 2015 | |
| NCT01709110 | Completed | Phase 4 | VERtebral Fracture Treatment Comparisons in Osteoporotic Women | October 2012 | July 2016 |
| NCT01750086 | Completed | Phase 4 | Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption | January 2013 | August 2014 |
| NCT01796301 | Completed | Phase 3 | An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women | January 31, 2013 | May 14, 2015 |
| NCT04431960 | Completed | Phase 1 | Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD Risk | July 20, 2021 | October 3, 2022 |
| NCT00086619 | Completed | Phase 2 | Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women | May 2004 | December 2009 |
| NCT00091793 | Completed | Phase 3 | Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis | August 2004 | March 2009 |
| NCT02598453 | Completed | Phase 4 | PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia | January 2005 | September 2006 |
| NCT02604836 | Completed | Phase 4 | A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia | June 2004 | April 2006 |
| NCT02791516 | Completed | Phase 3 | A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With Osteoporosis | January 16, 2017 | December 21, 2018 |
| NCT03026660 | Completed | N/A | Moringa Oleifera on Bone Density | July 2015 | May 2016 |
| NCT03472846 | Completed | Phase 4 | MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis | March 1, 2017 | September 30, 2022 |
| NCT03925051 | Completed | Phase 1 | Phase 1 Study to Compare CMAB807 Injection to Prolia® in Healthy Volunteers | July 1, 2019 | June 18, 2020 |
| NCT03970902 | Completed | Quality of Life in Postmenopausal Women With Osteoporosis | July 1, 2019 | April 1, 2022 | |
| NCT04026256 | Completed | Phase 4 | Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration | September 2, 2019 | April 18, 2022 |
| NCT04064411 | Completed | Phase 3 | Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis | August 5, 2019 | November 9, 2021 |
| NCT04169789 | Completed | N/A | Prevention of Early Postmenopausal Bone Loss With Lactobacillus Reuteri | December 4, 2019 | October 18, 2022 |
| NCT04366726 | Completed | Phase 1 | Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD) | April 9, 2019 | May 14, 2019 |
| NCT00079924 | Completed | Phase 4 | Effects of Teriparatide in Postmenopausal Women With Osteoporosis | November 2004 | May 2007 |
| NCT04653350 | Completed | N/A | High Intensity Multi-Modal Exercise Training in Postmenopausal Women | November 1, 2020 | June 10, 2022 |
| NCT04664959 | Completed | Phase 3 | A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis | November 26, 2020 | December 19, 2022 |
| NCT04702204 | Completed | Efficacy of Denosumab Treatment in Bisphosphonate Unresponsive Patients | July 1, 2020 | August 15, 2021 | |
| NCT04747392 | Completed | Phase 1 | Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults | August 19, 2020 | November 11, 2020 |
| NCT04873960 | Completed | Translation and Cross -Cultural Validation of ECOS-16 Questionnaire in Urdu Language | March 15, 2021 | May 25, 2022 | |
| NCT04934072 | Completed | Phase 3 | A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis | July 5, 2021 | August 7, 2023 |
| NCT05087030 | Completed | Phase 3 | Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis | September 21, 2021 | November 15, 2023 |
| NCT05346419 | Completed | N/A | Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients | July 1, 2021 | February 26, 2022 |
| NCT05347082 | Completed | N/A | Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment | April 29, 2021 | February 20, 2022 |
| NCT05650437 | Completed | N/A | Impact of Ultraviolet Radiation on Bone Density and Muscle Strength in Postmenopausal Women | December 30, 2022 | December 15, 2023 |
| NCT06457308 | Completed | N/A | Compare the Agility Exercise and Resistance Exercise on Physical Function and Stability in Osteoporotic Women | July 14, 2021 | December 31, 2022 |
| NCT02016716 | Completed | Phase 3 | A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis | December 3, 2013 | December 8, 2014 |
| NCT02128009 | Completed | Study on the microRNA Expression Level in Postmenopausal Osteoporosis | February 2014 | January 2017 | |
| NCT02157948 | Completed | Phase 3 | A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis | May 2014 | July 2015 |
| NCT02176382 | Completed | Phase 4 | Denosumab and Teriparatide Study (DATA-HD and DATA-EX) | August 2014 | February 2020 |
| NCT02234414 | Completed | Epidemiology, Identification Rate and Treatment Penetration of Osteoporotic Vertebral Fractures in Switzerland | February 2009 | June 2011 | |
| NCT02422069 | Completed | Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan | April 2010 | December 2011 | |
| NCT02478879 | Completed | Phase 1 | A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen | June 2015 | December 2015 |
| NCT02499237 | Completed | Phase 4 | Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuation | July 2015 | November 26, 2018 |
| NCT02598440 | Completed | Phase 4 | A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis | March 2004 | May 2005 |
| NCT00493532 | No longer available | A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. | June 2007 | December 2010 | |
| NCT06264401 | Not yet recruiting | N/A | Treatment Exercises With Core Stability and Dynamic Resistance Exercise for Postmenopausal Women With Osteoporosis | February 22, 2024 | December 31, 2024 |
| NCT05433207 | Not yet recruiting | Post-Marketing Drug Intensive Monitoring Surveillance of EDIROL in Patients With Postmenopausal Osteoporosis | August 1, 2022 | January 31, 2025 | |
| NCT04719650 | Not yet recruiting | Phase 4 | Clinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic Acid | October 2021 | November 2024 |
| NCT05645289 | Not yet recruiting | Phase 4 | Efficacy and Safety of Minodronate in Patients With Low Back Pain | January 1, 2023 | April 1, 2024 |
| NCT05060380 | Not yet recruiting | N/A | Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis | June 1, 2024 | December 1, 2025 |
| NCT06079476 | Recruiting | Phase 4 | A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture. | October 30, 2023 | November 1, 2025 |
| NCT05278338 | Recruiting | Phase 2 | Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis | April 21, 2022 | March 31, 2024 |
| NCT05902078 | Recruiting | Phase 4 | Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis | September 27, 2023 | December 2025 |
| NCT04591275 | Recruiting | Phase 3 | Clinical Efficacy and Safety Comparative Study Between CMAB807 Injection and Prolia® . | March 31, 2021 | November 1, 2024 |
| NCT05405725 | Recruiting | Phase 3 | A Phase 3 Study to Compare Biosimilar Denosumab With Prolia® | July 4, 2022 | August 2024 |
| NCT05630768 | Recruiting | Phase 4 | Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women | January 3, 2023 | February 2025 |
| NCT00529373 | Terminated | Phase 3 | A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018) | September 13, 2007 | February 1, 2017 |
| NCT04719481 | Unknown status | Phase 4 | Pravastatin Reduces Acute Phase Response of Zoledronic Acid | November 2021 | April 2022 |
| NCT04128163 | Unknown status | Phase 3 | Efficacy and Safety of QL1206 in the Treatment of Postmenopausal Osteoporosis With High Fracture Risk | June 5, 2019 | December 1, 2021 |
| NCT05060406 | Unknown status | Phase 3 | A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for Fracture | June 30, 2019 | December 31, 2021 |
| NCT01834105 | Unknown status | Phase 2 | Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1 | January 2012 | |
| NCT02854722 | Unknown status | Phase 2 | The Deferasirox-calcium-vitamin D3 Therapy for Postmenopausal Osteoporosis (PMOP) | January 15, 2018 | June 15, 2020 |
| NCT02981732 | Unknown status | N/A | CLCF1 Gene Associated With Postmenopausal Osteoporosis of Kidney Yin Deficiency Syndrome | October 2016 | December 2020 |
| NCT03512743 | Unknown status | Association of Serum Ferritin and Bone Mineral Density With Bone Metabolism in Chinese Healthy Postmenopausal Women | May 1, 2018 | June 1, 2019 | |
| NCT03720886 | Unknown status | Phase 1/Phase 2 | G56W1 in Women With Postmenopausal Osteoporosis | October 1, 2018 | August 31, 2020 |
| NCT04940845 | Unknown status | Phase 1 | Comparing of the Pharmacokinetic, Safety and Immunogenicity of HS-20090-2 Injection and Prolia® in Healthy Adults | July 26, 2021 | June 2022 |
| NCT01552122 | Withdrawn | Phase 3 | Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050) | May 2012 | February 2015 |
- ICD10 preferred id (Insert disease from ICD10)
- D0010732
- ICD10 class code (Insert disease from ICD10)
- M81.0